Volume should be selected to produce the working concentration required by the protocol see our reconstitution guide for worked examples
Patient Variation in Pernicious Anaemia, as Shown in a Clinical Trial of Cyanocobalamin, Hydroxocobalamin and CyanocobalaminZinc Tannate Variation between patients makes it impossible to anticipate the duration of effect of a single injection of one of these drugs in any patient
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Cobalt Allergy: Cyanocobalamin contains cobalt
Frequency: The dosing frequency depends on the indication
For a good evaluation, it is essential to follow this rule: DO NOT TRY TO REMEMBER WHAT YOUR SYMPTOMS WERE SIX MONTHS AGO, OR EVEN LONGER